<P>1. 허가사항 범위 내에서 환자의 증상 등에 따라 필요ㆍ적절하게 투여시 요양급여함을 원칙으로 함. [고시 제2010-39호]</P>
<P> </P>
<P>2. 허가사항 범위(효능ㆍ효과)를 초과하여 아래와 같이 투여한 경우에도 요양급여를 인정함.</P>
<P> - 아 래 -</P>
<P> 가. 절박유산과 관계가 있다고 추정되는 태반이나 탈락막의 혈전생성을 방지하기 위해 혈소판 응집억제 작용으로 저용량(80~100mg/day)을 투여한 경우</P>
<P> 나. 말초동맥성질환에 투여한 경우</P>
<P> </P>
<P>(시행일 : 2010.3.1)</P>
<P> </P>
<P>※ 관련근거</P>
<P> ㆍHarrison’s Principles of Internal Medicine, 17th Edition </P>
<P> ㆍGoldman : Cecil Medicine, 23rd Edition </P>
<P> ㆍBraunwald’s Heart Disease, A Textbook of Cardiovascular Medicine, 8th Edition</P>
<P> ㆍJoseph T. Dipiro Et Al. Pharmacotherapy, 6th Edition, 2005 </P>
<P> ㆍGoetz : Textbook of Clinical Neurology, 3rd Edition </P>
<P> ㆍ이우주의 약리학 강의, 제5판, 의학문화사, 2003년. p783 ~ 795.</P>
<P> ㆍ이광우 저, 신경과학 2005 p 229 ~ 231</P>
<P> ㆍ대한인터벤션영상의학회. 인터벤션영상의학. 일조각, 2007; 71-77.</P>
<P> ㆍ이영우 편저, 순환기학, 2001</P>
<P> ㆍMichael Sobel, et al. Antithrombotic Therapy for Peripheral Artery Occlusive Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition), Chest 2008;133;815-843 DOI 10.1378/chest.08-0686</P>
<P> ㆍNorgren L, et al. Inter-Society Consensus for the Management of peripheral arterial disease (TASC Ⅱ). Int Angiol 2007;26(2):81-157.</P>
<P> ㆍACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; Trans Atlantic Inter-Society Consensus; and Vascular Disease Foundation, Circulation. 2006 Mar 21;113(11):e463-654.</P>
<P> ㆍClopidogrel and modified-release dipyridamole in the prevention of occlusive vascular events. National Institute for Health and Clinical Excellence (NICE); 2005 May. 34 p.</P>
<P> ㆍManagement of Peripheral Arterial Disease, A peer-reviewed journal of the American Academy of Family Physicians February 1, 2004</P>
<P> ㆍExpert consensus document on the use of antiplatelet agents. The Task Force on the Use of Antiplatelet Agents in Patients with Atherosclerotic Cardiovascular Disease of the European Society of Cardiology. Eur Heart J 2004 Jan;25(2):166-81.</P>
<P> </P>
<P>※ 변경사유</P>
<P> 교과서 및 가이드라인 등을 참조하여 허가사항 범위를 초과하여 말초동맥성질환에 아스피린 경구제 요양급여를 인정합니다.</P>
<P> </P>
<P>※ 종전고시 : 고시제2001-28호('01.6.8)</P>
<!-- -->
